Literature DB >> 22897480

Investigation of selected cytokine genes suggests that IL2RA and the TNF/LTA locus are risk factors for severe alopecia areata.

S Redler1, F Albert, F F Brockschmidt, C Herold, S Hanneken, S Eigelshoven, K A Giehl, R Kruse, G Lutz, H Wolff, B Blaumeiser, M Böhm, T Becker, M M Nöthen, R C Betz.   

Abstract

BACKGROUND: Alopecia areata (AA) is the second most common cause of hair loss in humans, and has a genetically complex inheritance. The hypothesis that AA is autoimmune in nature is supported by previous studies. These report an association with specific HLA alleles, as well as genetic variants of other genes implicated in autoimmunity, such as various cytokine genes. However, these cannot yet be considered proven susceptibility loci, as many of these association findings were derived from small patient samples.
OBJECTIVES: To investigate the association between AA and selected cytokine genes using a sample of 768 patients with AA and 658 controls of Central European origin.
METHODS: Eleven single-nucleotide polymorphisms (SNPs) from cytokine genes implicated in previous AA studies were genotyped. These genes were IL1B, IL1A, IL1RN, MIF, IFNG and the TNF/LTA gene region. We also genotyped 15 SNPs selected from cytokine genes that have shown significant association with other autoimmune diseases. These genes were IL10, IL36RN, IL12B, IL6, IL2, IL23, IL2RA and IL4R.
RESULTS: Significant association was found for two variants within both IL2RA and TNF/LTA. In the overall sample, the most significant results were obtained for the IL2RA variant rs706778 (P = 0·00038) and the TNF/LTA locus variant rs1800629 (P = 0·0017). In subgroup analyses, according to severity, age at onset and family history these effects were stronger in the severely affected patients, with the lowest P-values being obtained for rs706778 (P = 3·8 × 10(-6) ).
CONCLUSIONS: Our results point to the involvement of IL2RA and the TNF/LTA region in the aetiology of AA, in particular severe AA, and provide further support for the hypothesis that AA is autoimmune in nature.
© 2012 The Authors. BJD © 2012 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22897480     DOI: 10.1111/bjd.12004

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  12 in total

1.  Immunochip-based analysis: high-density genotyping of immune-related loci sheds further light on the autoimmune genetic architecture of alopecia areata.

Authors:  Silke Redler; Marina Angisch; Stefanie Heilmann; Sabrina Wolf; Sandra Barth; Buket F Basmanav; Kathrin A Giehl; Sandra Hanneken; Sibylle Eigelshoven; Elisabeth Mangold; Roland Kruse; Bettina Blaumeiser; Markus Böhm; Michael Knapp; Natalie Garcia Bartels; Gerhard Lutz; Hans Wolff; Ulrike Blume-Peytavi; Markus M Nöthen; Tim Becker; Regina C Betz
Journal:  J Invest Dermatol       Date:  2014-10-22       Impact factor: 8.551

2.  The Immunogenetics of Alopecia areata.

Authors:  Fateme Rajabi; Fahimeh Abdollahimajd; Navid Jabalameli; Mansour Nassiri Kashani; Alireza Firooz
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Alternaria scalp infection in a patient with alopecia areata. Coexistence or causative relationship?

Authors:  Lidia Rudnicka; Malgorzata Lukomska
Journal:  J Dermatol Case Rep       Date:  2012-12-31

4.  Association between PTPN22 C1858T polymorphism and alopecia areata risk.

Authors:  Mauricio Salinas-Santander; Celia Sánchez-Domínguez; Cristina Cantú-Salinas; Hugo Gonzalez-Cárdenas; Ana Cecilia Cepeda-Nieto; Ricardo M Cerda-Flores; Rocío Ortiz-López; Jorge Ocampo-Candiani
Journal:  Exp Ther Med       Date:  2015-09-04       Impact factor: 2.447

Review 5.  What causes alopecia areata?

Authors:  K J McElwee; A Gilhar; D J Tobin; Y Ramot; J P Sundberg; M Nakamura; M Bertolini; S Inui; Y Tokura; L E King; B Duque-Estrada; A Tosti; A Keren; S Itami; Y Shoenfeld; A Zlotogorski; R Paus
Journal:  Exp Dermatol       Date:  2013-09       Impact factor: 3.960

6.  Alopecia universalis in a patient with rheumatoid arthritis developed during treatment with adalimumab.

Authors:  P Ostojic; S Pavlov-Dolijanovic
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

7.  Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci.

Authors:  Regina C Betz; Lynn Petukhova; Stephan Ripke; Hailiang Huang; Androniki Menelaou; Silke Redler; Tim Becker; Stefanie Heilmann; Tarek Yamany; Madeliene Duvic; Maria Hordinsky; David Norris; Vera H Price; Julian Mackay-Wiggan; Annemieke de Jong; Gina M DeStefano; Susanne Moebus; Markus Böhm; Ulrike Blume-Peytavi; Hans Wolff; Gerhard Lutz; Roland Kruse; Li Bian; Christopher I Amos; Annette Lee; Peter K Gregersen; Bettina Blaumeiser; David Altshuler; Raphael Clynes; Paul I W de Bakker; Markus M Nöthen; Mark J Daly; Angela M Christiano
Journal:  Nat Commun       Date:  2015-01-22       Impact factor: 14.919

8.  Severe subtype of alopecia areata is highly associated with thyroid autoimmunity.

Authors:  Ghada A Bin Saif
Journal:  Saudi Med J       Date:  2016-06       Impact factor: 1.484

9.  Serum concentrations of selected proinflammatory cytokines in children with alopecia areata.

Authors:  Katarzyna Tabara; Magdalena Kozłowska; Anna Jędrowiak; Wojciech Bienias; Andrzej Kaszuba
Journal:  Postepy Dermatol Alergol       Date:  2019-02-22       Impact factor: 1.837

10.  The association between rs2476601 polymorphism in PTPN22 gene and risk of alopecia areata: A meta-analysis of case-control studies.

Authors:  Zi-Xian Lei; Wen-Jing Chen; Jun-Qin Liang; Yan-Jun Wang; Lan Jin; Chen Xu; Xiao-Jing Kang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.